- ARRY has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $15.8 million.
- ARRY has traded 611,395 shares today.
- ARRY is up 3.3% today.
- ARRY was down 8% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ARRY with the Ticky from Trade-Ideas. See the FREE profile for ARRY NOW at Trade-Ideas More details on ARRY: Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. Currently there are 7 analysts that rate Array BioPharma a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Array BioPharma has been 2.2 million shares per day over the past 30 days. Array BioPharma has a market cap of $998.1 million and is part of the health care sector and drugs industry. The stock has a beta of 1.82 and a short float of 25% with 11.13 days to cover. Shares are up 51.1% year-to-date as of the close of trading on Tuesday.